ICH E6(R3) good clinical practice workshop with Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties

Date: 03/06/2020
Location: Virtual meeting

The aim of this workshop was to gather the views of European patients, healthcare professionals and clinical researchers on clinical trials and applying GCP, and their experiences related to these topics. This was in preparation for the revision of the International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E6 good clinical practice (GCP) guideline.

ICH decided to revise this guideline to ensure that it will be able address the increasing diversity of clinical-trial designs and data sources, and the different contexts in which clinical trials can be conducted.  The revision also aims to highlight the fact that GCP principles can be satisfied in a variety of ways.

ICH has committed itself to engaging stakeholders in the revision process from the outset, in particular patient representatives and academic clinical researchers. This aims to ensure that the final guideline will meet the needs of those conducting or participating in clinical trials.

EMA is coordinating the stakeholder engagement process on behalf of ICH in Europe. 

For more information on the revision of this guideline, see:


How useful was this page?

Add your rating
2 ratings
2 ratings